Clinical outcomes with alternative dosing strategies for piperacillin/tazobactam: a systematic review and meta-analysis

H Yang, C Zhang, Q Zhou, Y Wang, L Chen - PloS one, 2015 - journals.plos.org
Objectives A better dosing strategy can improve clinical outcomes for patients. We sought to
compare the extended or continuous infusion with conventional intermittent infusion of …

Evaluating outcomes associated with alternative dosing strategies for piperacillin/tazobactam: a qualitative systematic review

GT Mah, VH Mabasa, I Chow… - Annals of …, 2012 - journals.sagepub.com
Objective: To perform a qualitative systematic review of the evidence comparing traditional
strategies against prolonged intermittent or continuous infusion strategies for piperacillin …

Comparing clinical outcomes of piperacillin-tazobactam administration and dosage strategies in critically ill adult patients: a systematic review and meta-analysis

S Fawaz, S Barton, S Nabhani-Gebara - BMC Infectious Diseases, 2020 - Springer
Background Recently, continuous administration of piperacillin-tazobactam has been
proposed as a valuable alternative to traditional intermittent administration especially in …

The retrospective cohort of extended‐infusion piperacillin‐tazobactam (RECEIPT) study: a multicenter study

RJ Yost, DM Cappelletty… - … : The Journal of …, 2011 - Wiley Online Library
Study Objective. To compare the effectiveness of extended‐infusion piperacillin‐tazobactam
with that of similar‐spectrum, nonextended‐infusion β‐lactam antibiotics in the treatment of …

Prolonged vs intermittent infusion of piperacillin/tazobactam in critically ill patients: a narrative and systematic review

E Yusuf, H Spapen, D Piérard - Journal of critical care, 2014 - Elsevier
Purpose The purpose of this study is to review the rationale of prolonged (ie, extended or
continuous) infusion of piperacillin/tazobactam (PIP/TAZ) in critically ill patients and to …

Clinical outcomes of extended versus intermittent infusion of piperacillin/tazobactam in critically ill patients: a prospective clinical trial

SY Fan, HP Shum, WY Cheng, YH Chan… - … : The Journal of …, 2017 - Wiley Online Library
Study Objective To determine whether critically ill patients receiving extended‐infusion (EI)
piperacillin/tazobactam would have improved clinical outcomes compared with patients …

Prolonged infusion piperacillin-tazobactam decreases mortality and improves outcomes in severely ill patients: results of a systematic review and meta-analysis

NJ Rhodes, J Liu, JN O'Donnell, JM Dulhunty… - Critical care …, 2018 - journals.lww.com
Objective: Piperacillin-tazobactam is a commonly used antibiotic in critically ill patients;
however, controversy exists as to whether mortality in serious infections can be decreased …

Outcomes of extended-infusion piperacillin-tazobactam: a retrospective analysis of critically ill patients

GC Lee, H Liou, R Yee, CF Quan, K Neldner - Clinical therapeutics, 2012 - Elsevier
Studies evaluating the outcomes of an extended-infusion (EI) piperacillin-tazobactam dosing
strategy in specific cohorts of critically ill patients are lacking. A retrospective, pre …

Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam when administered by continuous infusion and intermittent dosing

DS Burgess, T Waldrep - Clinical therapeutics, 2002 - Elsevier
Background: Although intermittent bolus dosing is currently the standard of practice for many
antimicrobial agents, beta-lactams exhibit time-dependent bacterial killing. Maximizing the …

Pharmacokinetics of piperacillin–tazobactam: intermittent dosing versus continuous infusion

C Buck, N Bertram, T Ackermann, T Sauerbruch… - International journal of …, 2005 - Elsevier
In the present study 24 hospitalized patients requiring empirical antibiotic treatment were
randomly assigned to receive the β-lactam antibiotic/β-lactamase inhibitor combination …